All Stories

  1. Association of genetic variants in cyclin-dependent kinase 5 with Alzheimer's disease in a Saudi cohort

    Article • Journal of Alzheimer’s Disease, March 2026, SAGE Publications

    Dr Julie L Lavoie

  2. DNA Methylation Alterations in Benzene-Exposed Gasoline Station Workers: Insights from Singleplex MethyLight Analysis

    Article • ACS Chemical Health & Safety, February 2026, American Chemical Society (ACS)

    Dr Julie L Lavoie

  3. Rosiglitazone as a potential therapeutic drug in early intervention of preeclampsia

    Article • Pregnancy Hypertension, September 2025, Elsevier

    Dr Julie L Lavoie

  4. Association of MTHFR C677T and A1298C variants with preeclampsia risk and angiogenic imbalance in Tunisian women

    Article • Pregnancy Hypertension, March 2025, Elsevier

    Dr Julie L Lavoie

  5. Relation of rs846910, rs4844880 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) polymorphisms with the risk of preeclampsia: A case-control study

    Article • Gene Reports, December 2024, Elsevier

    Dr Julie L Lavoie

  6. Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia

    Article • Frontiers in Immunology, October 2023, Frontiers

    Dr Julie L Lavoie

  7. Preeclampsia is associated with reduced renin, aldosterone, and PlGF levels, and increased sFlt-1/PlGF ratio, and specific angiotensin-converting enzyme Ins-Del gene variants

    Article • Journal of Reproductive Immunology, June 2023, Elsevier

    Dr Julie L Lavoie

  8. Evaluation of the angiogenic factors sFlt‐1, PlGF, and the sFlt‐1/PlGF ratio in preeclampsia and associated features

    Article • American Journal of Reproductive Immunology, May 2023, Wiley

    Dr Julie L Lavoie

  9. Post‐exercise hypotension in male spontaneously hypertensive rats: The issue of calculation method

    Article • Physiological Reports, February 2023, Wiley

    Dr Julie L Lavoie

  10. Human forkhead box protein 3 gene variants associated with altered susceptibility to idiopathic recurrent pregnancy loss: a retrospective case‐control study

    Article • American Journal of Reproductive Immunology, April 2022, Wiley

    Dr Julie L Lavoie

  11. Contribution of -1031T/C and -376G/A tumor necrosis factor alpha polymorphisms and haplotypes to preeclampsia risk in Tunisia (North Africa)

    Article • Journal of Reproductive Immunology, February 2022, Elsevier

    Dr Julie L Lavoie

  12. MMP-2 and MMP-9 Polymorphisms and Preeclampsia Risk in Tunisian Arabs: A Case-Control Study

    Article • Journal of Clinical Medicine, June 2021, MDPI AG

    Dr Julie L Lavoie

  13. Phospho‐regulation, nucleotide binding and ion access control in potassium‐chloride cotransporters

    Article • The EMBO Journal, May 2021, EMBO

    Dr Julie L Lavoie

  14. Ultrasound Imaging of Remodeling in Fetal Mouse Heart and the Programming of Cardiomyopathy in Offspring of Superimposed Preeclampsia

    Article • Hypertension, May 2021, Wolters Kluwer Health

    Dr Julie L Lavoie

  15. A Longitudinal Pilot Study on Cognition and Cerebral Hemodynamics in a Mouse Model of Preeclampsia Superimposed on Hypertension: Looking at Mothers and Their Offspring

    Article • Frontiers in Physiology, February 2021, Frontiers

    Dr Julie L Lavoie

  16. Increased physical activity is correlated with improved pregnancy outcomes in women with preeclampsia: A retrospective study

    Article • Pregnancy Hypertension, July 2020, Elsevier

    Dr Julie L Lavoie

  17. IKZF1 genetic variants rs4132601 and rs11978267 and acute lymphoblastic leukemia risk in Tunisian children: a case-control study

    Article • BMC Medical Genetics, October 2019, Springer Science + Business Media

    Dr Julie L Lavoie

  18. 342. Association between Tumor Necrosis Factor Alpha (TNF-α) polymorphisms and haplotypes and preeclampsia risk

    Article • Pregnancy Hypertension, October 2018, Elsevier

    Dr Julie L Lavoie

  19. Impact of obesity on the association of active renin and plasma aldosterone concentrations, and aldosterone-to-renin ratio with preeclampsia

    Article • Pregnancy Hypertension, October 2018, Elsevier

    Dr Julie L Lavoie

  20. FAS A-670G and Fas ligand IVS2nt A 124G polymorphisms are significantly increased in women with pre-eclampsia and may contribute to HELLP syndrome: a case-controlled study

    Article • BJOG An International Journal of Obstetrics & Gynaecology, September 2018, Wiley

    Dr Julie L Lavoie

  21. Contribution of microRNA-149, microRNA-146a, and microRNA-196a2 SNPs in colorectal cancer risk and clinicopathological features in Tunisia

    Article • Gene, August 2018, Elsevier

    Dr Julie L Lavoie

  22. Mouse Adipose Tissue Collection and Processing for RNA Analysis

    Article • Journal of Visualized Experiments, January 2018, MyJove Corporation

    Dr Julie L Lavoie

  23. Mouse Adipose Tissue Collection and Processing for RNA Analysis

    Article • Journal of Visualized Experiments, January 2018, MyJove Corporation

    Dr Julie L Lavoie

  24. Interleukin-10 rs1800871 (−819C/T) and ATA haplotype are associated with preeclampsia in a Tunisian population

    Article • Pregnancy Hypertension, January 2018, Elsevier

    Dr Julie L Lavoie

  25. Contribution of angiotensinogen M235T and T174M gene variants and haplotypes to preeclampsia and its severity in (North African) Tunisians

    Article • Journal of the Renin-Angiotensin-Aldosterone System, January 2018, SAGE Publications

    Dr Julie L Lavoie

  26. Molecular insights into the normal operation, regulation, and multisystemic roles of K+-Cl− cotransporter 3 (KCC3)

    Article • AJP Cell Physiology, November 2017, American Physiological Society

    Dr Julie L Lavoie

  27. Vascular endothelial growth factor single nucleotide polymorphisms and haplotypes in pre-eclampsia: A case-control study

    Article • Cytokine, September 2017, Elsevier

    Dr Julie L Lavoie

  28. Role of the Renin-Angiotensin System in Healthy and Pathological Pregnancies

    Article • July 2017, IntechOpen

    Dr Julie L Lavoie

  29. Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk

    Article • European Journal of Human Genetics, August 2016, Nature

    Dr Julie L Lavoie

  30. Adipose tissue (P)RR regulates insulin sensitivity, fat mass and body weight

    Article • Molecular Metabolism, August 2016, Elsevier

    Dr Julie L Lavoie

  31. Prorenin/renin receptor blockade promotes a healthy fat distribution in obese mice

    Article • Obesity, July 2016, Wiley

    Dr Julie L Lavoie

  32. FGF1 and FGF2 mutations in preeclampsia and related features

    Article • Placenta, July 2016, Elsevier

    Dr Julie L Lavoie

  33. Oxytocin decreases diurnal and nocturnal arterial blood pressure in the conscious unrestrained spontaneously hypertensive rat

    Article • Pathophysiology, June 2016, Elsevier

    Dr Julie L Lavoie

  34. Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia

    Article • Cytokine, March 2016, Elsevier

    Dr Julie L Lavoie

  35. Estrogen and testosterone in concert with EFNB3 regulate vascular smooth muscle cell contractility and blood pressure

    Article • AJP Heart and Circulatory Physiology, February 2016, American Physiological Society

    Dr Julie L Lavoie

  36. Association of common eNOS/NOS3 polymorphisms with preeclampsia in Tunisian Arabs

    Article • Gene, September 2015, Elsevier

    Dr Julie L Lavoie

  37. EPHB4 Protein Expression in Vascular Smooth Muscle Cells Regulates Their Contractility, and EPHB4 Deletion Leads to Hypotension in Mice

    Article • Journal of Biological Chemistry, April 2015, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Julie L Lavoie

  38. [113-POS]

    Article • Pregnancy Hypertension, January 2015, Elsevier

    Dr Julie L Lavoie

  39. The prorenin/renin receptor contributes to obesity

    Article • Obesity, July 2014, Wiley

    Dr Julie L Lavoie

  40. Serine Carboxypeptidase SCPEP1 and Cathepsin A Play Complementary Roles in Regulation of Vasoconstriction via Inactivation of Endothelin-1

    Article • PLoS Genetics, February 2014, PLOS

    Dr Julie L Lavoie

  41. Physical activity prevents the development of preeclampsia

    Article • Hypertension, October 2013, Wolters Kluwer Health

    Dr Julie L Lavoie

  42. Impact of Exercise Training on Preeclampsia: Potential Preventive Mechanisms

    Article • Hypertension, October 2012, Wolters Kluwer Health

    Dr Julie L Lavoie

  43. OS060. Exercise training promotes placental growth and development in an animal model of preeclampsia superimposed on chronic hypertension

    Article • Pregnancy Hypertension, July 2012, Elsevier

    Dr Julie L Lavoie

  44. Possible Role of Efnb1 Protein, a Ligand of Eph Receptor Tyrosine Kinases, in Modulating Blood Pressure

    Article • Journal of Biological Chemistry, March 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Julie L Lavoie

  45. Receptor Tyrosine Kinase Ephb6 Regulates Vascular Smooth Muscle Contractility and Modulates Blood Pressure in Concert with Sex Hormones

    Article • Journal of Biological Chemistry, January 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Julie L Lavoie

  46. (Pro)renin Receptor as a New Drug Target

    Article • Current Pharmaceutical Design, November 2011, Bentham Science Publishers

    Dr Julie L Lavoie

  47. HCaRG Accelerates Tubular Repair after Ischemic Kidney Injury

    Article • Journal of the American Society of Nephrology, September 2011, American Society of Nephrology

    Dr Julie L Lavoie

  48. Can exercise prevent preeclampsia?

    Article • Journal of Hypertension, July 2011, Wolters Kluwer Health

    Dr Julie L Lavoie

  49. Exercise training can attenuate preeclampsia-like features in an animal model

    Article • Journal of Hypertension, September 2010, Wolters Kluwer Health

    Dr Julie L Lavoie

  50. Novel model of preeclampsia superimposed on chronic hypertension

    Article • Hypertension, October 2009, Wolters Kluwer Health

    Dr Julie L Lavoie

  51. Myogenic tone in mouse mesenteric arteries: evidence for P2Y receptor-mediated, Na+, K+, 2Cl− cotransport-dependent signaling

    Article • Purinergic Signalling, April 2009, Springer Science + Business Media

    Dr Julie L Lavoie

  52. Hyperhomocysteinemia alone does not cause preeclampsia

    Article • American Journal of Obstetrics and Gynecology, February 2009, Elsevier

    Dr Julie L Lavoie

  53. HCO3--Dependent Impact of Na+,K+,2Cl- Cotransport in Vascular Smooth Muscle Excitation-Contraction Coupling

    Article • Cellular Physiology and Biochemistry, January 2009, Cell Physiol Biochem Press GmbH and Co KG

    Dr Julie L Lavoie

  54. Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice

    Article • AJP Heart and Circulatory Physiology, November 2008, American Physiological Society

    Dr Julie L Lavoie

  55. Enzymatic Activity of Lysosomal Carboxypeptidase (Cathepsin) A Is Required for Proper Elastic Fiber Formation and Inactivation of Endothelin-1

    Article • Circulation, April 2008, Wolters Kluwer Health

    Dr Julie L Lavoie

  56. The Two fACEs of the Tissue Renin-Angiotensin Systems: Implication in Cardiovascular Diseases

    Article • Current Pharmaceutical Design, April 2007, Bentham Science Publishers

    Dr Julie L Lavoie

  57. Development of Hypertension and Kidney Hypertrophy in Transgenic Mice Overexpressing ARAP1 Gene in the Kidney

    Article • Hypertension, June 2006, Wolters Kluwer Health

    Dr Julie L Lavoie

  58. Evidence Supporting a Functional Role for Intracellular Renin in the Brain

    Article • Hypertension, January 2006, Wolters Kluwer Health

    Dr Julie L Lavoie

  59. Spontaneous Stroke in a Genetic Model of Hypertension in Mice

    Article • Stroke, June 2005, Wolters Kluwer Health

    Dr Julie L Lavoie

  60. Transgenic mice for studies of the renin-angiotensin system in hypertension

    Article • Acta Physiologica Scandinavica, August 2004, Wiley

    Dr Julie L Lavoie

  61. Increased renal renin-angiotensin system produces hypertension

    Article • AJP Renal Physiology, May 2004, American Physiological Society

    Dr Julie L Lavoie

  62. Adjacent Expression of Renin and Angiotensinogen in the Rostral Ventrolateral Medulla Using a Dual-Reporter Transgenic Model

    Article • Hypertension, March 2004, Wolters Kluwer Health

    Dr Julie L Lavoie

  63. Abnormal Coronary Function in Mice Deficient in  1H T-type Ca2+ Channels

    Article • Science, November 2003, American Association for the Advancement of Science

    Dr Julie L Lavoie

  64. Localization of renin expressing cells in the brain, by use of a REN-eGFP transgenic model

    Article • Physiological Genomics, November 2003, American Physiological Society

    Dr Julie L Lavoie

  65. Untraditional methods for targeting the kidney in transgenic mice

    Article • AJP Renal Physiology, November 2003, American Physiological Society

    Dr Julie L Lavoie

  66. Minireview: Overview of the Renin-Angiotensin System—An Endocrine and Paracrine System

    Article • Endocrinology, June 2003, Endocrine Society

    Dr Julie L Lavoie

  67. A farnesyltransferase inhibitor attenuated β-adrenergic receptor downregulation in rat skeletal muscle

    Article • AJP Regulatory Integrative and Comparative Physiology, January 2002, American Physiological Society

    Dr Julie L Lavoie

  68. Bradykinin facilitates noradrenaline spillover during contraction in the canine gracilis muscle

    Article • Canadian Journal of Physiology and Pharmacology, October 2001, Canadian Science Publishing

    Dr Julie L Lavoie

  69. TGF-β1 and prepro-ANP mRNAs are differentially regulated in exercise-induced cardiac hypertrophy

    Article • Journal of Applied Physiology, August 2001, American Physiological Society

    Dr Julie L Lavoie

  70. Bradykinin facilitates noradrenaline spillover during contraction in the canine gracilis muscle

    Article • Canadian Journal of Physiology and Pharmacology, January 2001, Canadian Science Publishing

    Dr Julie L Lavoie

  71. Effect of blood flow and muscle contraction on noradrenaline spillover in the canine gracilis muscle

    Article • Canadian Journal of Physiology and Pharmacology, January 2000, Canadian Science Publishing

    Dr Julie L Lavoie

  72. Effect of blood flow and muscle contraction on noradrenaline spillover in the canine gracilis muscle

    Article • Canadian Journal of Physiology and Pharmacology, December 1999, Canadian Science Publishing

    Dr Julie L Lavoie